1 The modulation of the y-aminobutyric acidA (GABAA) receptor by alphaxalone has been investigated by use of voltage-clamp recordings from enzymatically isolated bovine chromaffin cells maintained in cell culture. 2 Alphaxalone ( > 30 nM) reversibly and dose-dependently potentiated the amplitude of membrane currents elicited by locally applied GABA (100 ptM). The potentiation was not associated with a change in the reversal potential of GABA-evoked currents and was not influenced by the benzodiazepine receptor antagonist, Rol 5-1788 (300 nM). 3 At relatively high concentrations (>1 JM), alphaxalone directly elicited a membrane current. It is concluded that such currents result from GABAA receptor activation since they were reversibly suppressed by bicuculline (3 AM), dose-dependently enhanced by phenobarbitone (100-500 !LM), and had a similar reversal potential ( -0 mV) to currents elicited by GABA. Additionally, on outside-out membrane patches, alphaxalone activated single channel currents with amplitudes and a reversal potential similar to those evoked by GABA.4 Alphaxalone (30 nM-1 tiM) had no effect upon the amplitude of membrane currents elicited by locally applied acetylcholine (ACh) (100 pM). However, higher concentrations of alphaxalone (10-100 JM) reversibly suppressed ACh-evoked currents, the IC50 for blockade being 20 JAM.5 The P-hydroxy isomer of alphaxalone, betaxalone (100 nM-l pM), did not potentiate GABAinduced currents, nor did higher concentrations of the steroid (10-100 pM) directly evoke a membrane current. However, over the latter concentration range, betaxalone suppressed the amplitude of currents elicited either by GABA or ACh. 6 The relevance of the present results to the anaesthetic action of alphaxalone is discussed together with the broader implications of steroidal modulation of the GABAA receptor.